Last reviewed · How we verify
NCT06571318
Clinical Study to Reduce Premature Ejaculation in Healthy Adult Men
NA trial testing Destress and Perform Capsule-U001 in Premature Ejaculation in 60 participants. Not yet recruiting.
20 November 2024
Quick facts
| Lead sponsor | Herbolab India Pvt. Ltd. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 5 September 2024 |
| Primary completion | 20 November 2024 |
| Estimated completion | 28 December 2024 |
Drugs / interventions tested
- Destress and Perform Capsule-U001
- Destress and Perform Capsule-I001
- Placebo capsules 002
Conditions studied
- Premature Ejaculation — all drugs for Premature Ejaculation →
- Stress — all drugs for Stress →
Sponsor
Herbolab India Pvt. Ltd.
Who can join
Adults 21 to 50, male only, with Premature Ejaculation or Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current study focuses on clinical validation of efficacy of nutraceutical product in management of male health. In healthy adult men with induced premature ejaculation, the introduction of these nutraceuticals has been associated with notable improvements in quality of life. These supplements help them for enhanced sexual satisfaction, increased control over ejaculation, and a reduction in performance anxiety. The psychological benefits are significant, as the improvement in sexual function can lead to higher self-confidence and a more positive outlook on life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06571318
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Premature Ejaculation
Currently open trials in the same condition.
- NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
- NCT07434271 — Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outc · Phase 2 · recruiting
- NCT06570135 — Brain Activity During Sexual Behavior in Patients With Primary Premature Ejaculation a Clinical Trial · NA · recruiting
- NCT06851598 — Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation · Phase 2, PHASE3 · active not recruiting
- NCT06605469 — Ejaculatory and Orgasmic Dysfunction Registry · recruiting
Other Herbolab India Pvt. Ltd. trials
Trials by the same sponsor.
- NCT06571071 — A Clinical Study of De-Stress & Chill Gummies in Reducing Stress · NA · not yet recruiting
- NCT06571331 — A Clinical Trial of De-Stress & Snooze Gummies in Reducing Stress and Insomnia Disorder · NA · not yet recruiting
- NCT06569849 — A Clinical Trial of De-stress and Focus Capsule in the Management of Stress. · NA · not yet recruiting
- NCT06568965 — Clinical Study of De-Stress & Happy Gut Powder for Stress and Indigestion in Adults. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06571318 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Herbolab India Pvt. Ltd.
- Last refreshed: 26 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06571318.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing